Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Arsenic Trioxide,Calcium Carbonate
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 18, 2025
Lead Product(s) : Arsenic Trioxide,Calcium Carbonate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Famotidine,Calcium Carbonate,Magnesium Hydroxide
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Akums Launches Dual Action Heartburn Relief Chewable Tablet
Details : Dual action heartburn relief chewable tablet, consisting Famotidine (H2 receptor antagonist), Calcium Carbonate and Magnesium Hydroxide have been approved and launched in indian market.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 10, 2024
Lead Product(s) : Famotidine,Calcium Carbonate,Magnesium Hydroxide
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 05, 2024
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 01, 2024
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluoride,Fluorophosphate,Mfp,Calcium Carbonate,Tin Fluoride
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 20, 2023
Lead Product(s) : Fluoride,Fluorophosphate,Mfp,Calcium Carbonate,Tin Fluoride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lansoprazole,Calcium Carbonate
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 06, 2023
Lead Product(s) : Lansoprazole,Calcium Carbonate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 13, 2023
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Danicopan,Cyclosporine,Tacrolimus,Calcium Carbonate,Aluminum,Magnesium Hydroxide,Simethicone,Omeprazole
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Alexion Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 05, 2021
Lead Product(s) : Danicopan,Cyclosporine,Tacrolimus,Calcium Carbonate,Aluminum,Magnesium Hydroxide,Simethicone,Omeprazole
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Alexion Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Acalabrutinib,Calcium Carbonate,Omeprazole,Rifampicin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 07, 2021
Lead Product(s) : Acalabrutinib,Calcium Carbonate,Omeprazole,Rifampicin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 25, 2021
Lead Product(s) : Calcium Carbonate,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable